Venous Thromboembolism Treatment Market Size, Share, and Forecast Indicate Accelerated Adoption
The global venous thromboembolism (VTE) treatment market is projected to reach a valuation of US$2.9 billion by the end of 2031, rising from an estimated US$2.2 billion in 2024. This reflects a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031, indicating steady expansion driven by advancements in drug development, diagnostic technologies, and digital health integration. With a...
0 Comments 0 Shares 14 Views 0 Reviews